Stock Recommendations for September 16, 2026: PN Gadgil, Mankind Pharma, BEML
On September 16, 2026, investors are presented with stock recommendations from Ganesh Dongre, Senior Manager of Technical Research at Anand Rathi Shares and Stock Brokers Limited. The highlighted stocks include PN Gadgil Jewellers, Mankind Pharma, and BEML, each accompanied by specific buying ranges and target prices.
For PN Gadgil Jewellers, the recommendation is to buy within the range of Rs 600 to Rs 620, with a stop-loss set at Rs 580. The target prices are set at Rs 650 and Rs 670. The stock is showing a positive technical setup, indicated by a trendline breakout in the Rs 590 to Rs 610 zone, suggesting an improving price structure. The MACD indicator is entering an oversold zone, which may support a potential recovery in momentum.
For Your Trading Desk
Sponsor Spike Success.
Mankind Pharma is recommended for purchase between Rs 2250 and Rs 2280, with a stop-loss at Rs 2200. The targets for this stock are Rs 3380 and Rs 2450. The stock has demonstrated a strong recovery from lower levels and is maintaining its position above key moving averages, indicating a positive broader trend. A decisive close above the Rs 2230 to Rs 2250 range could confirm a breakout, opening up further upside potential.
Investment Insights and Recommendations for BEML's Stock Performance
BEML is also on the watchlist, with a buying recommendation between Rs 2060 and Rs 2080, a stop-loss at Rs 2020, and target prices of Rs 2280 and Rs 2350. This stock is supported by its involvement in defense, railway, and infrastructure sectors. Currently, it is consolidating in a sideways pattern following a recent correction. A decisive move above the previous swing high of Rs 2080, along with increasing volumes, would indicate renewed buying interest.
Overall, these recommendations reflect a cautiously optimistic outlook for the stocks mentioned, with specific technical indicators guiding potential investment decisions.




